View in EDS HTML Full Text PDF Full Text

Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.

Saved in:
Bibliographic Details
Title: Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.
Authors: Kobayashi RH; UCLA School of Medicine, Los Angeles, CA, United States., Gupta S; Division of Basic and Clinical Immunology, University of California, Irvine, Irvine, CA, United States., Melamed I; IMMUNOe Research Center, Centennial, CO, United States., Mandujano JF; Pediatric Pulmonary Associates of North Texas, Frisco, TX, United States., Kobayashi AL; Midlands Pediatrics, Papillion, NE, United States., Ritchie B; Division of Hematology, Department of Medicine, University of Alberta Hospital, Edmonton, AB, Canada., Geng B; Divisions of Adult and Pediatric Allergy and Immunology, University of California, San Diego, La Jolla, CA, United States., Atkinson TP; Department of Pediatric Allergy, Asthma and Immunology, University of Alabama, Birmingham, AL, United States., Rehman S; Allergy and Asthma Center Inc., Toledo, OH, United States., Turpel-Kantor E; Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria., Litzman J; Department of Clinical Immunology and Allergology, St Anne's University Hospital in Brno, Faculty of Medicine, Masaryk University, Brno, Czechia.
Source: Frontiers in immunology [Front Immunol] 2019 Feb 04; Vol. 10, pp. 40. Date of Electronic Publication: 2019 Feb 04 (Print Publication: 2019).
Publication Type: Case Reports; Research Support, Non-U.S. Gov't; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30778345
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kobayashi+RH%22">Kobayashi RH</searchLink>; UCLA School of Medicine, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Gupta+S%22">Gupta S</searchLink>; Division of Basic and Clinical Immunology, University of California, Irvine, Irvine, CA, United States.<br /><searchLink fieldCode="AU" term="%22Melamed+I%22">Melamed I</searchLink>; IMMUNOe Research Center, Centennial, CO, United States.<br /><searchLink fieldCode="AU" term="%22Mandujano+JF%22">Mandujano JF</searchLink>; Pediatric Pulmonary Associates of North Texas, Frisco, TX, United States.<br /><searchLink fieldCode="AU" term="%22Kobayashi+AL%22">Kobayashi AL</searchLink>; Midlands Pediatrics, Papillion, NE, United States.<br /><searchLink fieldCode="AU" term="%22Ritchie+B%22">Ritchie B</searchLink>; Division of Hematology, Department of Medicine, University of Alberta Hospital, Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Geng+B%22">Geng B</searchLink>; Divisions of Adult and Pediatric Allergy and Immunology, University of California, San Diego, La Jolla, CA, United States.<br /><searchLink fieldCode="AU" term="%22Atkinson+TP%22">Atkinson TP</searchLink>; Department of Pediatric Allergy, Asthma and Immunology, University of Alabama, Birmingham, AL, United States.<br /><searchLink fieldCode="AU" term="%22Rehman+S%22">Rehman S</searchLink>; Allergy and Asthma Center Inc., Toledo, OH, United States.<br /><searchLink fieldCode="AU" term="%22Turpel-Kantor+E%22">Turpel-Kantor E</searchLink>; Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Litzman+J%22">Litzman J</searchLink>; Department of Clinical Immunology and Allergology, St Anne's University Hospital in Brno, Faculty of Medicine, Masaryk University, Brno, Czechia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2019 Feb 04; Vol. 10, pp. 40. <i>Date of Electronic Publication: </i>2019 Feb 04 (<i>Print Publication: </i>2019).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Research Support, Non-U.S. Gov't; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30778345
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2019.00040
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 40
    Titles:
      – TitleFull: Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kobayashi RH
      – PersonEntity:
          Name:
            NameFull: Gupta S
      – PersonEntity:
          Name:
            NameFull: Melamed I
      – PersonEntity:
          Name:
            NameFull: Mandujano JF
      – PersonEntity:
          Name:
            NameFull: Kobayashi AL
      – PersonEntity:
          Name:
            NameFull: Ritchie B
      – PersonEntity:
          Name:
            NameFull: Geng B
      – PersonEntity:
          Name:
            NameFull: Atkinson TP
      – PersonEntity:
          Name:
            NameFull: Rehman S
      – PersonEntity:
          Name:
            NameFull: Turpel-Kantor E
      – PersonEntity:
          Name:
            NameFull: Litzman J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 02
              Text: 2019 Feb 04
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 10
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1